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Abstract
Background: Chlamydia trachomatis is the most common bacterial sexually transmitted disease in the world with 
severe complications. The aim of  this study was to determine the prevalence and possible risk factors of  C. 
trachomatis in Kano. There is dearth of  information on this subject in this locality.
Method: Urine samples, Endocervical swabs and Urethral swab were collected from consecutive patients attending 
the Infertility and STD clinics in Aminu Kano Teaching Hospital (AKTH) between June and December 2012, 
after administering a questionnaire by the attending physician and also obtaining an informed consent.Samples 
were analyzed using Diaspot Chlamydia kit, a rapid immunoassay test for the detection of  genital chlamydial 
antigen in urinogenital samples.
Results: A total of  125 consecutive samples were collected, comprising 69 females and 56 males aged between 
14 – 55 years. Twelve samples tested positive for C. trachomatis antigen giving a prevalence rate of  9.6%. The age 
group prevalence were as follows 25 – 29 yrs (17.1%), 20 – 24 (16.7%), 15 – 19 (12.5%), 30 – 34 (11.1%) and > 49 
years (9.0%). Married patients were associated with higher infection rate than single (8.3%), and divorced patients 
(33.3%). A higher percentage of  the patients (95.2%) were not aware of  the existence of  C. trachomatis infection 
and its complications. Previous STD exposure was associated with increased risk of  Chlamydia infection. 
Conclusion: C. trachomatis infection if  unchecked will continue to pose a threat to reproductive life with its 
established complications. Since asymptomatic cases are common in the population regular screening should be 
encouraged for every adult especially before commencement of  marital life.
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Introduction
Chlamydia trachomatis is a non-motile, small Gram-
negative bacterium that is an obligate intracellular 
parasite1.
Genital infection caused by C. trachomatis is generally 
asymptomatic. Approximately 50% of  infected males 
and 80% of  infected females show no symptoms, but 
infection may cause a mucopurulent cervicitis in females 
and urethritis in males2. Commonly unrecognized 
and often poorly or inadequately treated, Chlamydia 
infections can ascend the reproductive tract resulting 
in pelvic inflammatory disease (PID) and, consequently, 
lead to chronic pelvic pain, ectopic pregnancy, and 
infertility3.
Owing to varied characteristics of  the study population 
and different methods used for Chlamydia detection, 
there is a wide variation in prevalence rates of  Chlamydia 
infection4. Approximately 4 million cases of  Chlamydia 
infection are reported per year in the US, with an 
overall prevalence of  5%5. In Ethiopia6, the prevalence 
rate for Chlamydia infection of  the cervix was 5.9%. 
Among unsuspecting women attending antenatal clinic 
in Benin City, Nigeria7, a prevalence rate of  13.3% was 
noted, while Nwanguma et al.8 reported a prevalence of  
33% in asymptomatic volunteers in another Nigerian 
population.
In many developed countries, screening 
programmes for Chlamydia have been set up to 
reduce transmission and reproductive tract morbidity9. 
The United States Centers for Disease Control and 
         672African Health Sciences Vol 14 Issue 3, September 2014
  Corresponding  author.
   Nwankwo.E. O
   Department of  microbiology, 
   Kogi State University,  Anyigba.
   emmaonwubiko@yahoo.com
Prevention recommend annual screening of  all sexually 
active women aged 25 or less10, as is screening of  older 
women with risk factors (for example, those who have 
a new sex partner or multiple sex partners).
Materials and methods
Participants included patients attending Infertility 
and STD clinics in AKTH. Informed consent was 
obtained from the patients after which the attending 
physician administered a questionnaire that had been 
validated by other researchers. Demographic details as 
well as questions on sexual behavior, such as previous 
exposure to STD, awareness of  C. trachomatis infection 
and its complications including diagnosis at the time of  
attending the clinic were obtained. 
A total of  125 consecutive samples comprising 69 
endocervical swabs from the Infertility clinic, 53 urine 
and 3 urethral swabs from the STD clinic, AKTH were 
collected from patients between June – December 
2012 and processed according to the manufacturers 
(Interchemical Shenzhen Ltd. China) instruction in the 
Microbiology laboratory Department of  AKTH 
Specimen collection: 
The quality of  specimen obtained is of  extreme 
importance as the detection of  Chlamydia requires 
thorough collection technique that provides cellular 
materials rather than just body fluid.
Sample analysis
The Chlamydia Rapid Test Device (Swab/Urine) is a 
qualitative, lateral flow immunoassay for the detection 
of  Chlamydia antigen from female cervical swab, male 
urethral swab and male urine specimens. In this test, 
antibodies specific to Chlamydia antigen is coated on 
the test line region of  the test. During testing, the 
extracted antigen solution reacts with an antibody to 
Chlamydia that is coated onto particles. The mixture 
migrates up to react with the antibody to Chlamydia on 
the membrane and generates a colored line in the test 
line region. The presence of  this colored line in the test 
line region indicates a positive result, while its absence 
indicates a negative result. To serve as a procedural 
control, a colored line will always appear in the control 
line region, indicating that proper volume of  specimen 
has been added and membrane wicking has occurred.    
Samples were collected and processed according to the 
detailed instruction in the manufacturers leaflet11.
Statistical analysis
Epi info version 6 was used for Fisher exact and chi 
squared analysis. Statistical significance was accepted at 
P<0.05 (95% confidence limits). 
Simple percentages were used to compare rates. 
Results
A total of  125 samples in all were tested for C. 
trachomatis antigen out of  which 12 tested positive 
giving a prevalence rate of  9.6% in the study. However, 
a prevalence rate of  8.7% was observed from the 
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Infertility clinic while 10.7% was observed in the STD clinics.
The age and sex distribution of  both screened and infected patients were presented in Table 1. The highest age 
group prevalence rate occurred in 24 – 29 (17.1%) followed by 20 – 24 (16.7%), 15 – 19 (12.5%) and > 49 years 
(9.0%).
Table 1: Age and Sex distribution of  screened and infected patients for Chlamydia trachomatis.
Age (yrs) No. Screened (%) Total No. 
screened (%)




(%)M F M F
< 15 0 (0) 1 (1.4) 1 (0.8) 0 (0.0) 0 (0.0) 0 (0.0) 0
15 – 19 2 (3.6) 6 (8.7) 8 (6.4) 1 (16.7) 0 (0.0) 1 (8.3) 12.5
20 – 24 2 (3.6) 4 (5.8) 6 (4.8) 0 (0.0) 1 (16.7) 1 (8.3) 16.9
25 – 29 15 (26.8) 20 (29.0) 35 (28.0) 3 (50.0) 3 (50.0) 6 (50.0) 17.1
30 – 34 12 (21.4) 15 (21.7) 27 (21.6) 2 (33.3) 1 (16.7) 3 (25.0) 11.1
35 – 39 5 (8.9) 8 (11.6) 13 (10.4) 0 (0.0) 0 (0.0) 0 (0.0) 0
40 – 44 13 (23.2) 6 (8.7) 19 (15.2) 0 (0.0) 0 (0.0) 0 (0.0) 0
45 – 49 2 (3.6) 3 (4.3) 5 (4.0) 0 (0.0) 0 (0.0) 0 (0.0) 0
> 49 5 (8.9) 6 (8.7) 11 (8.8) 0 (0.0) 1 (16.7) 1 (8.3) 100
Total 56 69 125 6 6 12
Table 2 shows the infection rate in different specimens/clinic. While a prevalence rate of  8.7% was observed in 
infertility clinic where endocervical swabs were used, 10.7% was seen in STD clinic where urine and Urethral 
samples were collected. However, there was no statistical significance. X2 = 2.01, df2 P = 0.37
Table 2: Prevalence of  Chlamydia trachomatis in relation to clinical samples
Types of Samples No. of samples screened (%) No. positive (%)
ECS 69 (55.2) 6 (50)
US 3 (2.4) 1(8.3)
UR 53 (42.4) 5 (41.7)
Total 125 12
X2 = 2.01, df2 P = 0.37
ESC:  Endocervical Swab
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US: Urethral Swab
UR: Urine
Table 3 shows the prevalence of  Chlamydia trchomatis in relation to marital status. The highest prevalence of  58.3% 
occurred in married women followed by divorced patients 33.3%. (X2 = 11.0 df2 P <0.002)
Table 3: Prevalence of  Chlamydia trachomatis in relation to marital status.
Marital status No. screened (%) No. positive (%)
Single 2 (1.6) 1 (8.3)
Married 110 (88) 7 (58.3)
Divorced 13 ( 10.4) 4 (33.3)
Total 125 12
X2 = 11.0, df2 P< 0.002
Table 4 shows the prevalence of  C trachomatis in relation to awareness. Majority of  the patients 119 (95.2%) were 
not aware of  the existence of  Chlamydia trachomatis while 6 (4.8%) were aware. All 11 (91.7%) out of  12 infected 
persons were unaware of  this infection. (Fisher exact P>0.05)
Table 4: Prevalence of Chlamydia trachomatis in relation to awareness.
Awareness No. screened (%) No. positive (%)
Aware 6 (4.8) 1 (8.3)
Not aware 119 (95.2) 11 (91.7)
Total 125 12
Fisher exact P> 0.05
Table 5 shows the prevalence of  Chlamydia trachomatis in relation to previous STD exposure. The highest infection 
rate (75%) was observed in persons with previous STD exposure. (X2 = 5.18 df2 P>0.07)
Table 5: Prevalence of  Chlamydia trachomatis in relation to previous STD exposure.
Previous STD exposure No. screened (%) No. positive (%)
Yes 55 (44) 9 (75.0)
No 48 (38.4) 2 (16.7)
No response 22 (17.6) 1 (8.3)
Total 125 12
X2 = 5.18, df2, P = 0.007
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Table 6 shows the prevalence of  Chlamydia trachomatis in relation to provisional diagnosis or health factor. The 
highest infection occurred in patients from the STD clinic 50%, closely followed by those for Infertility evaluation 
41.7%. (X2 = 20.6, df2 P<0.003)
      Table 6: Prevalence of  Chlamydia trachomatis in relation to clinical diagnosis.
Diagnosis No. screened (%) No. positive (%)
Infertility 10 (8) 5 (42.7)
STD 90 (72) 6 (50)
PID 25 (2) 1 (8.3)
Total 125 12
X2 = 20.6, df2, P< 0.003
Discussion
Even among the educated people, knowledge of  
Chlamydia infection and its associated complications is 
very low. 
The actual incidence of  Chlamydia infection in 
developing countries is difficult to establish due to 
many factors. There is a socio cultural inhibition that 
prevents women from reporting sexual symptoms, non 
availability of  facility to detect the organism in many 
health clinics and the asymptomatic nature of  the disease 
12, 13. In spite of  these limitations, it is still reported that 
there is a high prevalence of  the chlamydia infection in 
most parts of  Africa [] 14
Laboratory methods of  testing for Chlamydia include 
cell culture, polymerase chain reaction and enzyme 
immunoassay. There is a wide variation in the cost, 
sensitivities and specificities of  these methods 3. As 
a result of  the different characteristics of  the study 
population and different methods used for Chlamydia 
detection, there is a wide variation in prevalence rates 
of  Chlamydia infection 4.
 In the present study, the risk factors observed include 
age, marital status, previous history of  STD, lack of  
awareness and provisional diagnosis on reporting to the 
clinic. However, significant association was found with 
marital status and provisional diagnosis on reporting to 
clinic such as infertility, STD, and pelvic inflammation 
disease.
These observations were consistent with the findings 
of  other researchers in their centres . 15, 16
The prevalence of  Chlamydia infection in this finding 
was 9.6%. This is in agreement with the report from 
Ibadan 10% 17 but at variance with the findings in 
other part of  Nigeria which showed higher figures. 
Two reports from Lagos had a wide margin in their 
observations 51% 18 and 18.2% 16 prevalence. Other 
reports from Jos, South Eastern parts of  Nigeria, Zaria 
and Benin city showed prevalence rates of  51.6% 15, 
40.7% 19, 38.3% 20 and 13.3%21 respectively. 
This is however in contrast to the observation from 
some countries such as United States of  America where 
approximately 4 million cases of  Chlamydia infection 
are reported annually with an overall prevalence of  5% 
5 and in Ethiopia 5.9% 6. 
These observed differences in prevalence rates could 
be due to study population and laboratory methods of  
identification.
In analysis of  age group prevalence 24-29 yrs had the 
highest with 17.1% followed by 20-24 yrs in this study. 
These are age groups of  high sexual activity and this 
may be responsible for high prevalence observed. Also 
married patients were observed to be more affected 
than the singles and divorced. The numbers of  sexual 
partners may have played a role in the observed 
increased incidence in married ones because the study 
population was predominantly polygamous with some 
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having remarried about twice. It was however difficult 
to obtain information in this regard because of  socio 
cultural inhibitions.
The observation made in the study of  age group 
prevalence and marital status is in agreement with the 
findings of  other researchers 15, 16
A significant association which was seen between health 
factor or some disease states such as secondary infertility 
and sexually transmitted disease were reported by other 
researchers 15, 16.
A very high percentage of  the patients in this study, 
95.2% were completely ignorant of  the existence of  
Chlamydia infection and consequently do not know of  
it associated complication.
Some researchers have observed that men constitute 
a large reservoir of  Chlamydia infection and could 
repeatedly reinfect their partners without knowing 
it 22. A major problem in this situation is the lack of  
diagnostic facilities in most laboratories to confirm 
genital Chlamydia infection such as ectopic pregnancy, 
infertility. It is suggested that a screening program should 
be organized by the appropriate authorities on a regular 
basis to check the ever presence of  Chlamydia infection 
in the population. Secondly, all intending couples must 
be tested before they can start a marital life. All those 
found positive should be treated and counseled as a 
means of  control of  the infection.
We advocate an awareness campaign through mass 
education of  the populace about Chlamydia infection 
especially, mode of  transmission, complications 
including prevention and control. This could be done 
through hand bills and electronic media including regular 
seminars for both literate and illiterate population in the 
society.      
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